Synthesis, characterization, and in vitro antitumor activity of osteotropic diam(m)ineplatinum(II) complexes bearing a N,N-bis(phosphonomethyl)glycine ligand.
Markus Galanski, Susanna Slaby, Michael A Jakupec, Bernhard K Keppler
文献索引:J. Med. Chem. 46(23) , 4946-51, (2003)
全文:HTML全文
摘要
A series of osteotropic (bone-seeking) [(bis(phosphonomethyl)amino-kappaN)acetato-kappaO(2-)]platinum(II) complexes attached to diammine, ethane-1,2-diamine, cis-R,S-cyclohexane-1,2-diamine, trans-S,S-cyclohexane-1,2-diamine, or trans-R,R-cyclohexane-1,2-diamine has been synthesized in accord with the concept of drug targeting and characterized by elemental analysis, (1)H, (13)C, and (31)P NMR spectroscopy. The in vitro antitumor activity in ovarian cancer cells (CH1) has been determined by means of the MTT assay. In this cisplatin-sensitive cell line the complexes containing cyclohexane-1,2-diamine (chxn) displayed a high activity in comparison to the diammine and ethane-1,2-diamine counterparts. In agreement with structure-activity relationships of other chxn-containing platinum(II) complexes both [(bis(phosphonomethyl)amino-kappaN)acetato-kappaO(2-)](trans-cyclohexane-1,2-diamine)platinum(II) complexes show superior potency than the corresponding cis-congener whereas the trans-R,R isomer displays the highest activity. Within the series of complexes under investigation, potency decreases depending on the coordinated amine ligand in the following order: trans-R,R-chxn > trans-S,S-chxn > NH(3) > or = cis-R,S-chxn > en.
相关化合物
相关文献:
2011-12-01
[J. Immunol. 11th ed., 187 , 5921-5930, (2011)]
1991-07-16
[Biochemistry 30(28) , 6930-6, (1991)]
1984-03-01
[Toxicology 30(2) , 103-14, (1984)]
2005-12-01
[Electrophoresis 26(23) , 4478-85, (2005)]
1997-08-19
[Biochemistry 36(33) , 10105-8, (1997)]